CLINICAL_TRIALS
research
· 2024-12-11
Clinical Trial Update: The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.
Summary
Ongoing clinical trial evaluating Ga-68 grazytracer PET imaging to monitor responses to immunotherapy in pancreatic cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ruijin Hospital | Conditions: Pancreatic Cancer | Status: RECRUITING